Skip to content
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Evolving Psychedelic Paradigm
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
JCP Podcast
Rounds in the General Hospital
View All
Webcast
Recent JCP Articles on Webcast
JCP
Webcast
Pharmacotherapies for Early-Stage Alzheimer Disease
May 25, 2021
How do investigational drugs for Alzheimer disease differ from those currently prescribed to patients? Dr Burke shares her insights.
Anna D. Burke
JCP
Webcast
Discussing Early-Stage AD With Patients
May 11, 2021
In this webcast about early-stage Alzheimer disease, Drs Burke and Apostolova highlight important conversations to have with patients and their care partners on topics such as diet, exercise, driving,...
Anna D. Burke
,
Liana Apostolova
JCP
Webcast
Assessment for Alzheimer Disease
May 4, 2021
What are the steps for diagnosing Alzheimer disease? Are you familiar with diagnostic criteria and assessment tools? In this webcast, walk through the process with an expert.
Liana Apostolova
Featured
Webcast Research
JCP
Original Research
Effects of Brexpiprazole on Functioning in Patients with Schizophrenia Who Have Hostility and Agitation Symptoms
July 20, 2026
This post hoc analysis showed that brexpiprazole may improve functioning in adults with schizophrenia, even if they have hostility and agitation symptoms.
Leslie Citrome
,
Anja Farovik
,
Anton M. Palma
, et al
Does TMS Work for Depression? What Clinicians Should Know
July 17, 2026
PCC
Case Report
Mirtazapine-Induced Severe Hyponatremia
July 16, 2026
A 30-year-old man developed severe hyponatremia after starting mirtazapine, highlighting the importance of closely monitoring sodium levels when starting any antidepressant in patients already taking oxcarbazepine.
Nathan R. Luzum
,
Sahil Munjal
